Source: International Congress 2019 – Drug-resistant tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
C. Seijger (Nijmegen, Netherlands), W. Hoefsloot (Nijmegen, Netherlands), I. Bergsma (Nijmegen, Netherlands), J. Van Ingen (Nijmegen, Netherlands), S. Kuijpers (Nijmegen, Netherlands), L. Te Brake (Nijmegen, Netherlands), R. Van Crevel (Nijmegen, Netherlands), R. Aarnoutse (Nijmegen, Netherlands), M. Boeree (Nijmegen, Netherlands), C. Magis-Escurra (Nijmegen, Netherlands). High-dose rifampicin in tuberculosis: experiences from a Dutch tuberculosis centre. 2132

Member's Comments

No comment yet.

Related content which might interest you: Tuberculosis 1995–2004: evaluation of the resistance of mycobacterium tuberculosis to anti-TBC drugs in Greece Source: Eur Respir J 2006; 28: Suppl. 50, 589s Year: 2006 Frequency of rifampicin resistance in re-treatment cases of pulmonary tuberculosis using Gene-Xpert in a tertiary care hospital tuberculosis clinic Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 High-dose rifampicin and rifapentine in tuberculosis treatment Source: International Congress 2015 – Tuberculosis: short-course chemotherapy Year: 2015 Multi drug resistant (rifampicin + isoniazid) pulmonary tuberculosis – a challenge for a developing country specially co-infected with HIV Source: Eur Respir J 2007; 30: Suppl. 51, 421s Year: 2007 Treatment with isoniazid or rifampin for latent tuberculosis infection: population-based study of hepatotoxicity, completion and costs Source: Eur Respir J, 55 (3) 1902048; 10.1183/13993003.02048-2019 Year: 2020 Drug resistance trends and patterns of mycobacterium tuberculosis isolates from pulmonary tuberculosis patients at a tertiary care hospital in Turkey Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012 Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experience Source: Eur Respir J 2016; 47: 333-336 Year: 2016 Pulmonary tuberculosis with primary drug resistant mycobacterium tuberculosis -treatment outcomes Source: Eur Respir J 2004; 24: Suppl. 48, 657s Year: 2004 Multidrug resistance of M. tuberculosis and its infuence on treatment efficiency of new detected patients with pulmonary tuberculosis in penitentiary institutions of Belarus Source: Eur Respir J 2007; 30: Suppl. 51, 272s Year: 2007 Direct molecular testing for isoniazid and rifampicin resistance from respiratory specimens of patients with tuberculosis Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III Year: 2013 Spread of tuberculosis among household contacts of multi drug resistant tuberculosis (MDRTB) patients Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Effectiveness of intravenous isoniazid and ethambutol administration in patients with new smear positive drug-susceptible pulmonary tuberculosis with tuberculous meningoencephalitis and HIV co-infection in the intensive phase of treatment Source: International Congress 2019 – Tuberculosis: treatment and management Year: 2019 Management of multidrug-resistant tuberculosis and patients in retreatment Source: Eur Respir J 2005; 25: 928-936 Year: 2005 Resistance to pyrazinamide of Mtb strains in TB institute clinic Source: Eur Respir J 2007; 30: Suppl. 51, 413s Year: 2007 Prevalence of cross-resistance between rifampicin and rifabutin in Mycobacterium tuberculosis isolates in a tertiary care hospital in India Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis Year: 2010 Primary drug resistant Mycobacterium tuberculosis in a tertiary TB center in Iran Source: Eur Respir J 2005; 26: Suppl. 49, 651s Year: 2005 Efficacy and safety of linezolid for the treatment of multidrug resistant tuberculosis (MDR-TB) and disease by non tuberculous mycobacteria (NTM) Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011 Experience of using Diaskintest by tuberculosis patients Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012 Efficacy of intravenous administration of anti-tuberculosis drugs in patients with multidrug-resistant tuberculosis Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Drag resistant M. tuberculosis among tuberculosis patients in prisons Source: Eur Respir J 2001; 18: Suppl. 33, 313s Year: 2001